Rosa Santacroce

Rosa Santacroce

Auto-generated profile, based on publicly available information

Rosa Santacroce

A Genetica Medica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Foggia , Foggia, Italy and

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2002 in Human Mutation
Verified
Journal Article
Closed access
PDF file
AFAlessandro Ferraris
Alessandro Ferraris
EREric Rappaport
Eric Rappaport
RSRosa Santacroce
Rosa Santacroce
EPEleanor Pollak
Eleanor Pollak
IKIan Krantz
Ian Krantz
PFPaolo Fortina
Paolo Fortina
Hereditary hearing loss (HHL) is one of the most common congenital disorders and is highly heterogeneous. Mutations in the connexin 26 (CX26) gene (GJB2) account for about 20% of all cases of childhood deafness, and approach 50% in documented recessive cases of non-syndromic hearing loss. In addition, a single mitochondrial DNA mutation, mt1555A>G, in the 12S rRNA gene (MTRNR1), is associated with familial cases of progressive deafness. Effective screening of populations for HHL necessitates rapid assessment of several of these potential mutation sites. Pyrosequencing links a DNA synthesis protocol for determining sequence to an enzyme cascade that generates light whenever pyrophosphate is released during primer strand elongation. We assessed the ability of Pyrosequencing to detect common mutations causing HHL. Detection of the most common CX26 mutations in individuals of Caucasian (35delG), Ashkenazi (167delT), and Asian (235delC, V37I) descent was confirmed by Pyrosequencing. A total of 41 different mutations in the CX26 gene and the mitochondrial mt1555A>G mutation were confirmed. Genotyping of up to six different adjacent mutations was achieved, including simultaneous detection of 35delG and 167delT. Accurate and reproducible results were achieved taking advantage of assay flexibility and experimental conditions easily optimized for a high degree of standardization and cost-effectiveness. The standardized sample preparation steps, including target amplification by PCR and preparation of single-stranded template combined with automated sequence reaction and automated genotype scoring, positions this approach as a potentially high throughput platform for SNP/mutation genotyping in a clinical laboratory setting. Hum Mutat 20:312–320, 2002.

1 October 2009 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
RSRosa Santacroce
Rosa Santacroce
VLVittoria Longo
Vittoria Longo
VBValeria Bafunno
Valeria Bafunno
Francesco SessaFrancesco Sessa
Francesco Sessa
Chetta MassimilianoChetta Massimiliano
Chetta Massimiliano
MMMaurizio Margaglione
Maurizio Margaglione
Aim: Hemophilia A is an X-linked bleeding disorder caused by mutations widespread in the human coagulation F8 gene. Apart from common intrachromosomal translocations, most of the mutations in the F8 gene are detectable using genomic sequencing analysis. However, deletions of one or more exons or deletion encompassing the entire gene can go undetected, especially in heterozygous females. Results: The multiplex ligation–dependent probe amplification is an efficient tool, new and fast, for discovering these rearrangements. In this study different deletions, which were detected using multiplex ligation–dependent probe amplification assay on 25 patients affected by severe hemophilia A, were classified as “mutation negative” by sequencing analysis. Conclusions: These data suggest that this screening could be systematically included in genetic screening of patients with Hemophilia A.

13 August 2015 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Closed access
PDF file
RSRosa Santacroce
Rosa Santacroce
RTRoberta Trunzo
Roberta Trunzo
ALAngelica Leccese
Angelica Leccese
APAngela Pansini
Angela Pansini
MGMattia Gentile
Mattia Gentile
MMMaurizio Margaglione
Maurizio Margaglione
(2015). The first case of a small supernumerary marker chromosome derived from chromosome 10 in an adult woman with an apparently normal phenotype. Systems Biology in Reproductive Medicine: Vol. 61, No. 6, pp. 398-402. doi: 10.3109/19396368.2015.1067936